Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-17-000002

Director acquired 88,679 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dash Barry H Director 2017-02-23 Grant or award +88,679 $0.23 $19,997 1,254,457 D
Loading xslF345X03/primary_doc.xml…